Delivery Order SPE2DB22D1103-SPE2DB24FTQL1

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product. The contract has a firm fixed price of $24,016.22 and the ultimate completion date is August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TREMFYA 100 MG/ML syringes. The contract has a firm fixed price, with a ceiling value of $21,445.95, and an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which enables the...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order is for TREMFYA 100 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $43,257.72 and a completion date of October 31, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. As a primary...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has a ceiling value of $31,239.15 and a completion date of October 9, 2024. It is a firm-fixed-price contract, without a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite Delivery Contract (IDC) valued up...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TREMFYA 100 MG/ML SYRINGEML. The order, valued at $73,161.62, has a firm fixed price and an ultimate completion date of August 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $20,501.98 and a period of performance through July 3, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order is for the pharmaceutical product TREMFYA 100 MG/ML SYRINGE with a ceiling value of $16,824.00 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $54,949.91, is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of November 1, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
The U.S. Defense Logistics Agency (DLA) awarded a $27,203.88 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of TREMFYA 100 MG/ML INJECTORML pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies from...
This is a $16,533.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TREMFYA 100 MG/ML syringes and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTQL1
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of TREMFYA 100 MG/ML SYRINGEML, a specialty pharmaceutical product. The ceiling value of this order is $11,961.19, with an ultimate completion date of August 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a range of medical commodities, including prescription drugs and other medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/20/24, 9:15 AM